1. Home
  2. ANIX vs FURY Comparison

ANIX vs FURY Comparison

Compare ANIX & FURY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.49

Market Cap

119.8M

Sector

Health Care

ML Signal

HOLD

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.60

Market Cap

115.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
FURY
Founded
1982
2008
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
119.8M
115.0M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
ANIX
FURY
Price
$3.49
$0.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$8.67
$1.70
AVG Volume (30 Days)
209.9K
285.6K
Earning Date
05-27-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$0.50
52 Week High
$5.46
$1.02

Technical Indicators

Market Signals
Indicator
ANIX
FURY
Relative Strength Index (RSI) 58.73 58.38
Support Level $2.73 $0.57
Resistance Level $3.89 $0.64
Average True Range (ATR) 0.20 0.03
MACD 0.01 -0.00
Stochastic Oscillator 69.92 44.82

Price Performance

Historical Comparison
ANIX
FURY

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.

Share on Social Networks: